Skip to main content

Table 2 Comparison of characteristics between SLE patients with and without organ damage accrual stratified by SLICC damage index score

From: Relationship of systemic type I interferon activity with clinical phenotypes, disease activity, and damage accrual in systemic lupus erythematosus in treatment-naive patients: a retrospective longitudinal analysis

 

SDI = 0 (n = 24)

SDI ≥ 1 (n = 16)

p value*

Female, n (%)

23 (96)

14 (88)

0.553

Age of onset, median (IQR), years

29 (24–41)

36 (24–46)

0.456

Observation period, median (IQR), years

7.9 (4.3–9.6)

5.7 (1.2–9.6)

0.308

SLEDAI-2K at baseline, median (IQR), score

10 (8–14)

14 (8–19)

0.207

Lupus nephritisa, n (%)

9 (38)

11 (69)

0.105

Lupus anticoagulant positive, n (%)

5 (21)

7 (44)

0.166

Anti-cardiolipin antibody positive, n (%)

11 (46)

8 (50)

0.999

Number of patients who had flareb, n (%)

14 (58)

8 (50)

0.748

Number of flares/patient, median (IQR), n

1 (0–1.75)

0.5 (0–1.75)

0.647

Serum IFN activity at baseline, median (IQR), score

57.3 (17.9–137.2)

150 (51.1–275.4)

0.018

Serum IFN activity at 2nd point, median (IQR), score

0.2 (0.0–6.0)

0.9 (0.0–15.5)

0.639

Induction dose of prednisolone, median (IQR), mg/day

38 (30–50)

43 (33–50)

0.273

Methylprednisolone pulse, n (%)

0 (0)

4 (25)

0.020

IVCY, n (%)

2 (8)

7 (44)

0.018

MMF, n (%)

8 (33)

8 (50)

0.339

HCQ, n (%)

5 (21)

7 (44)

0.166

CNIs, n (%)

11 (46)

9 (56)

0.748

  1. CNIs calcineurin inhibitors, HCQ hydroxychloroquine, IFN type I interferon, IVCY intravenous cyclophosphamide, MMF mycophenolate mofetil, SDI Systemic Lupus International Collaborating Clinics (SLICC) damage index, SLEDAI-2K SLE Disease Activity Index 2000
  2. aThe presence of lupus nephritis (LN) was defined as proteinuria ≥ 0.5 g/24 h or biopsy-proven nephritis compatible with SLE according to the EULAR/ACR2019 criteria renal domain [23]
  3. bDisease flares were assessed according to the modified Safety of Estrogen in Lupus Erythematosus National Assessment (SELENA)-SLEDAI Flare Index without the physician global assessment (PGA) score [29]
  4. *p values were calculated with the chi-square test, Fisher’s exact test, or Mann-Whitney test. p values < 0.05 were considered significant